Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOR-SAFE
NCT07778511Recruiting
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Morphine with Placebo (2 arms). Primary endpoints: Self-report of subjective stress during stress exposure, Endocrinological markers of stress response at 105 minutes and 7 more. Started Sep 2026; status: recruiting.
02
Drugs
morphine
Beyond the preview
Go deeper on NCT07778511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07778511.